Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Characterization of Bleeding in Thrombotic Thrombocytopenic Purpura Treated without Caplacizumab

Amir Mahmoud, Purva Shah, Basant Eltaher, Mariam A Mostafa, Ali Abdelhay, Mouhamed Yazan Abou-Ismail, Shruti Chaturvedi

Blood (2024) 144 (Supplement 1): 2619.

https://doi.org/10.1182/blood-2024-202649

Published: 2024

Journal Articles

Can Machine Learning Supplant the Plasmic Score in Improving the Early Diagnosis of Thrombotic Thrombocytopenic Purpura?

Mouhamed Yazan Abou-Ismail, Rishabh Singh, Sanjana Kashinath, Mukul Singal, Ashley Khouri, Cecilia Peterson, Ho Jun Lee, Carley Mitchell, Simon-Bahos Bechara, Manasa Kandula, Chong Zhang, Peter A. Kouides, Lalitha Nayak, Ming Y Lim

Blood (2024) 144 (Supplement 1): 2617.

https://doi.org/10.1182/blood-2024-200446

Published: 2024

Journal Articles

Clonal Persistence of Anti-PF4 Antibodies in VITT Represents an MGTS-like State

Adam Kanack, Guillaume Roberge, Emily Mauch, Noah Splinter, Geoffrey D. Wool, Gemlyn George, Mouhamed Yazan Abou-Ismail, Kristi J. Smock, David L. Green, Krishna Gundabolu, Jon Coker, Mindy Kohlhagen, David Murray, Anand Pabmanabhan

Blood (2024) 144 (Supplement 1): 1227.

https://doi.org/10.1182/blood-2024-208364

Published: 2024

Journal Articles

Double-heterozygous FVL/PTGM: double the trouble

Ming Y. Lim, Mouhamed Yazan Abou-Ismail

Blood (2024) 143 (23): 2347–2349.

https://doi.org/10.1182/blood.2024024411

Published: 2024

Journal Articles

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT

Adam J. Kanack, Antonios Bayas, Gemlyn George, Mouhamed Yazan Abou-Ismail, Bandana Singh, Mindy C. Kohlhagen, Noah P. Splinter, Monika Christ, Markus Naumann, Karen A. Moser, Kristi J. Smock, Alison Grazioli, Renren Wen, Demin Wang, David L. Murray, Anand Padmanabhan

Blood (2022) 140 (1): 73–77.

https://doi.org/10.1182/blood.2021014588

Published: 2022

Includes: Supplemental data

Journal Articles

A Descriptive Analysis of Immune Thrombotic Thrombocytopenic Purpura (iTTP) Patients with Fatal Outcomes in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela Presson, Marshall Mazepa, Ming Yeong Lim, United States Thrombotic Microangiopathies Consortium Investigators

Blood (2021) 138 (Supplement 1): 4227.

https://doi.org/10.1182/blood-2021-154292

Published: 2021

Journal Articles

Bortezomib for the Management of Relapsed or Refractory Warm Autoimmune Hemolytic Anemia: A Scoping Review

Eric Johnson, Nicholas Lesh, Gregory Hildebrand, Harsh Shah, Afaf Osman, Mouhamed Yazan Abou-Ismail

Blood (2021) 138 (Supplement 1): 4149.

https://doi.org/10.1182/blood-2021-153437

Published: 2021

Journal Articles

A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-Treated Cryopreserved Platelets for the Detection of Pathogenic HIT and VITT Antibodies

Adam Kanack, Curtis Jones, Bandana Singh, Gemlyn George, Mouhamed Yazan Abou-Ismail, David L. Green, Alison Grazioli, Rachel Leger, Nahla M. Heikal, Dong Chen, Rajiv K. Pruthi, Anand Padmanabhan

Blood (2021) 138 (Supplement 1): 2130.

https://doi.org/10.1182/blood-2021-152953

Published: 2021

Journal Articles

Mortality in Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) Is Unpredictable: Poor Statistical Performance of Mortality Prediction Models

Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela Presson, Marshall Mazepa, Ming Yeong Lim, United States Thrombotic Microangiopathies Consortium Investigators

Blood (2021) 138 (Supplement 1): 771.

https://doi.org/10.1182/blood-2021-146282

Published: 2021

Journal Articles

Outcomes after Treatment with Upfront Cyclophosphamide or Rituximab for Initial Acquired Thrombotic Thrombocytopenic Purpura

Mouhamed Yazan Abou-Ismail, MD, Yasmin Arafah, MD, Pingfu Fu, PhD, Shufen Cao, Alvin H. Schmaier, MD, Lalitha V. Nayak, MD

Blood (2019) 134 (Supplement_1): 1084.

https://doi.org/10.1182/blood-2019-123537

Published: 2019

Journal Articles

"Outgrowing" the Laboratory Diagnosis of Type 1 Von Willebrand's Disease: A Two Decade Study

Mouhamed Yazan Abou-Ismail, MD, Gbolahan O. Ogunbayo, MD, Peter A. Kouides, MD

Blood (2016) 128 (22): 871.

https://doi.org/10.1182/blood.V128.22.871.871

Published: 2016

NARROW

Characterization of Bleeding in Thrombotic Thrombocytopenic Purpura Treated without Caplacizumab

Can Machine Learning Supplant the Plasmic Score in Improving the Early Diagnosis of Thrombotic Thrombocytopenic Purpura?

Clonal Persistence of Anti-PF4 Antibodies in VITT Represents an MGTS-like State

Double-heterozygous FVL/PTGM: double the trouble

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT

A Descriptive Analysis of Immune Thrombotic Thrombocytopenic Purpura (iTTP) Patients with Fatal Outcomes in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Bortezomib for the Management of Relapsed or Refractory Warm Autoimmune Hemolytic Anemia: A Scoping Review

A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-Treated Cryopreserved Platelets for the Detection of Pathogenic HIT and VITT Antibodies

Mortality in Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) Is Unpredictable: Poor Statistical Performance of Mortality Prediction Models

Outcomes after Treatment with Upfront Cyclophosphamide or Rituximab for Initial Acquired Thrombotic Thrombocytopenic Purpura

"Outgrowing" the Laboratory Diagnosis of Type 1 Von Willebrand's Disease: A Two Decade Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only